PERFECT MEDICAL (01830) Announces Interim Results: Profit Attributable to Shareholders HK$145 million, Up 52.93% Year-on-Year
PERFECT MEDICAL (01830) Announces Interim Results for the Six Months Ended September 30, 2026: Revenue HK$483 million, Down 0.62% Year-on-Year; Profit Attributable to Equity Holders of the Company HK$145 million, Up 52.93% Year-on-Year; Basic Earnings Per Share HK11.5 cents. Proposed Interim Dividend of HK11.5 cents Per Share.
PERFECT MEDICAL (01830) Announces Interim Results for the Six Months Ended September 30, 2026: Revenue HK$483 million, Down 0.62% Year-on-Year; Profit Attributable to Equity Holders of the Company HK$145 million, Up 52.93% Year-on-Year; Basic Earnings Per Share 11.5 HK cents. Proposed Interim Dividend of 11.5 HK cents Per Share.
The announcement stated that the significant improvement in profitability despite broadly unchanged revenue fully reflects the earnings leverage unleashed by the leaner operating platform the Group established during the period through streamlining its network scale, rigorous cost restructuring, and optimization of its service mix. Key operating cost items, including employee benefits, marketing and promotion, inventory and consumables costs, and other operating expenses, all declined period-on-period. With the major phase of network consolidation largely completed, the Group is now in a stronger position to achieve sustainable profit growth.
Related Articles

MANULIFE-S (00945) plans to issue subordinated debentures with a principal amount of C$750 million.

WuXi AppTec (02359): Court approves dismissal of 1260H lawsuit
.png)
SNACK EMPIRE (01843) subsidiary intends to sell Singapore property.
MANULIFE-S (00945) plans to issue subordinated debentures with a principal amount of C$750 million.

WuXi AppTec (02359): Court approves dismissal of 1260H lawsuit

SNACK EMPIRE (01843) subsidiary intends to sell Singapore property.
.png)





